Barb Nickel, APRN-CNS, CCRN, CRNI®, is a Clinical Nurse Specialist at a large health care system in the United States, responsible for staff development and process improvement to optimize outcomes in multiple areas of clinical practice, including critical care, infusion therapy, sepsis, and new graduate transition to practice. Ms Nickel has presented nationally and published in several peer-reviewed journals on infusion-related topics. She was the Chair of the 2024 INS Infusion Therapy Standards of Practice (SOP)Committee, and is now Chair of the 2027 INS SOP Committee. She also serves as Adjunct Research Fellow for Griffith University, Queensland, Australia.

Robert Garcia is an infection preventionist/consultant and has been a member of the Association for Professionals in Infection Control and Epidemiology (APIC) since 1980. In 2016, he was selected as a fellow at the Association for Professionals in Infection Control and Epidemiology (APIC), a designation for experienced IPs who have had significant contributions to the field of infection prevention. He is the certification infection preventionist/director at nine hospitals in New York City and the principal researcher on the effectiveness of silver-hydrogel urinary catheters, chlorhexidine skin antisepsis, and comprehensive oral care. Robert is a current or former member of APIC’s National Strategic Planning Board, Education Committee, and/or CBIC, as well as a trainer for APIC’s EPI Clinical Course. He is a contributor to APIC’s Text of Infection Control and Epidemiology; was a reviewer for the 2005 HICPAC Guidelines on Isolation; and since 2001 has been an editorial board member and/or reviewer for the American Journal of Infection Control, where in 2016 he was ranked among the top 25th percentile of reviewers. He has more than 100 publications and media interviews ranging from institutional costs of infection to prevention of HAIs to environmental contamination to microbiology to reducing occupational exposures.

Nancy Moureau, PhD, RN, CRNI®, CPUI, VA-BC, is a globally recognized leader and the founder of PICC Excellence, Inc., a premier provider of education on infusion therapy and vascular access device (VAD) insertion and care for over 3 years. Dr Moureau’s extensive clinical experience includes pediatric, neonatal, intensive care unit (ICU) peripherally inserted central catheter (PICC)/IV teams, and home infusion care.

As CEO of PICC Excellence, she leads the development of over 8 online educational courses and pathways, emphasizing insertion competency and evidence-based practices. Her responsibilities include education development, research, global speaking engagements, legal reviews, manufacturer consulting, and active clinical practice for peripheral and central vascular access.

Dr Moureau pioneered PICC Certification™ (CPUI™) and Neonatal PICC Credentialing (CNPI) programs, validating inserters' education and competency. Most recently, she introduced a systematic UGPIV Mastery Learning Process, an ultrasound-guided peripheral insertion toolbox that earned the Infusion Nurses Society’s (INS) Seal of Approval—the first of its kind.

To connect with Dr Moureau, visit www.piccexcellence.com, or email her at nancy@piccexcellence.com.

Joan Harvey, DNP, RN, BC, CCRN, has extensive experience in Critical Care Nursing and Gerontology. She is board certified in both and currently sits on a panel for the ANCC as a content expert for the Gerontological exam. She is a Professor at Georgian Court University, teaching Generic BSN students. Her passion for safe medication use dates to when she was at the graduate nurse level. She remains focused on quality education regarding safe medication administration.

Susan Heidenwolf Weaver, PhD, RN, CRNI®, NEA-BC, is a nurse scientist at the Ann May Center for Nursing at Hackensack Meridian Health and the New Jersey Collaborating Center for Nursing. Sue has experience as an ICU nurse and Nurse Educator, with responsibility for teaching the IV Course, Operations Manager and Evening Administrative Supervisor. As a nurse scientist, Sue has conducted research on the nursing workforce, with a focus on the evening and night administrative supervisor role. Sue has presented and has been published on critical “behind the scenes” nurse leadership roles. Sue lives in Lake Mohawk, New Jersey, has 3 great children and is a basket weaver!

Ahmad Sediq, PhD, is a pharmacist with a PhD degree in pharmaceutical technology from Leiden University in the Netherlands. Dr Sediq worked as a formulation scientist at Janssen Vaccines in the Netherlands, where he was responsible for late-stage development and commercial launch of adeno-associated virus- (AAV)-vector-based vaccine products for Ebola and human immunodeficiency virus (HIV). He joined Lonza DPS in 2018, where he was principal scientist and group leader in the Formulation Development group. At Lonza, his team was responsible for early- and late-stage drug product development of various biological formats. In 2022, Dr Sediq joined Roche/Genentech, where he is taking the lead of early- and late-stage drug product design and development for treatment of inflammatory bowel disease and lung cancer. 

Dr Sediq is interested in applying his technical and scientific knowledge into pharmaceutical care and treatment. Therefore, he is passionate of performing research at the interface of pharmaceutical technology and clinical practice. 

Jeannine Blake, PhD, RN, is a nurse scientist with a clinical background in surgical intensive care nursing and a passion for advancing health care innovation using an interdisciplinary nurse-engineer approach. Her research focuses on improving intravenous (IV) pumping technology accuracy, flow steadiness, and usability, with a current interest in understanding the impact of alarm management on nursing time and patient experience. She is dedicated to improving patient outcomes, streamlining nursing workflows, and integrating IV pumps more effectively into real-world clinical practices.

Dr Blake earned her PhD in Nursing Science and completed a Postdoctoral Research Fellowship in Mechanical and Industrial Engineering at the University of Massachusetts Amherst. She is now an Assistant Professor in the Elaine Marieb College of Nursing and is affiliated with the Elaine Marieb Center for Nursing and Engineering Innovation. She continues her research mission in this role to build evidence that informs infusion practices and optimizes nursing workflows.

Dr Blake contributes to the development of global safety standards for infusion therapy as a member of the Association for the Advancement of Medical Instrumentation (AAMI) technical information report (TIR) Infusion Standards Committee and has been an invited clinical advisor to the International Electrotechnical Commission (IEC) Infusion Standards Working Group. For her work in this space, she is the 2025 AAMI Young Professional Award winner.

Prof. Victor D. Rosenthal, MD, PhD, is a specialist in Internal Medicine and infectious diseases with an Infection Prevention fellowship at Wisconsin University and a certification in Clinical Effectiveness from Harvard University. He is a Professor in the Public Health Department at the University of Miami.

Since 2002, he has been the Founder and Chief Scientific Officer of the International Nosocomial Infection Control Consortium (INICC), which researches the surveillance and prevention of central line-associated bloodstream infections (CLABSIs) in 45 countries in Latin America, Asia, Africa, the Middle East, and Eastern Europe. In this setting, he has led over 2,500 researchers. Over the last 30 years, he has been a keynote speaker at thousands of events in 900 cities in 71 countries.

He has 421 scientific publications, which have been cited in over 28,500 peer-reviewed papers. His H index is 72. He serves on the editorial boards of the American Journal of Infection Control (AJIC) and other journals, reviews over 100 peer-reviewed journals, including The Lancet, and has received 10 international awards for his research, including those of APIC and the Society for Healthcare Epidemiology of America (SHEA).

He has collaborated as an editor-in-chief or reviewer of standards for several scientific organizations, including the Infusion Nurses Society (INS), International Society of Infectious Diseases (ISID), Association for Vascular Access (AVA), Joint Commission International (JCI), World Health Organization (WHO), and the governments of Hong Kong, Taiwan, Colombia, Brazil, and Argentina. He is the Editor-in-Chief and Committee Member of the INS Infusion Therapy Standards of Practice, to be published in 2027, and the editor-in-chief of the 2024 ISID Guidelines to Prevent CLABSI.